Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Background & Aims</h3><p>Our previous genomic whole-exome sequencing (WES) data identified the key ErbB pathway mutations that play an essential role in regulating the malignancy of gallbladder cancer (GBC). Here, we tested the hypothesis that individual cellular components of the tumor microenvironment (TME) in GBC function differentially to participate in ErbB pathway mutation-dependent tumor progression.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Methods</h3><p>We engaged single-cell RNA sequencing to reveal transcriptomic heterogeneity and intercellular crosstalk from 13 human GBC and adjacent normal tissues. In addition, we performed WES analysis to reveal the genomic variations related to tumor malignancy. A variety of bulk RNA sequencing, immunohistochemical staining, immunofluorescence staining and functional experiments were employed to study the difference between ErbB pathway mutation and non-mutation tissues.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>We identified sixteen cell types from a total of 114,927 cells, in which epithelial cells, M2 macrophages, and Treg were predominant in ErbB pathway mutation tumors. Furthermore, epithelial cell subtype 1, 2 and 3 were mainly found in the adenocarcinoma and subtype 4 was present in adenosquamous carcinoma. The ErbB pathway mutation tumors harbored larger populations of epithelial cell subtype 1 and 2, and expressed higher levels of secreted midkine (MDK) than non-ErbB pathway mutation tumors. Increased MDK resulted in interaction with its receptor LRP1 expressed by tumor infiltrating macrophages and promoted immuno-suppressive macrophage differentiation. Moreover, the crosstalk between macrophage-secreted CXCL10 and its receptor CXCR3 on Tregs was induced in GBC with ErbB pathway mutations. Elevated MDK was correlated with poor overall survival of GBC patients.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusions</h3><p>This study has provided valuable insights into transcriptomic heterogeneity and the global cellular network in the TME, which coordinately functions to promote the progression of GBC with ErbB pathway mutations; thus unveiling novel cellular and molecular targets for cancer therapy.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Lay summary</h3><p>We employed single-cell RNA sequencing and functional assays to reveal transcriptomic heterogeneity and intercellular crosstalk in GBC patients. GBC cancers were characterized with heterogenic cellular ecosystem in which the ErbB pathway mutations were associated with anti-cancer immunity and cancer development. Increased MDK from cancer cells of ErbB pathway mutation tumors resulted in interaction with its receptor LRP1 expressed by tumor infiltrating macrophages and promoted immuno-suppressive macrophage differentiation. In addition, the crosstalk between macrophage-secreted CXCL10 and its receptor CXCR3 on Tregs was induced in GBC with ErbB pathway mutations, which contributes to GBC progression.</p>

Single-cell RNA-seq reveals transcriptional landscape and intratumor heterogenicity in gallbladder cancer liver metastasis microenvironment

Diversity and Intratumoral Heterogeneity in Human Gallbladder Cancer Progression Revealed by Single‐cell RNA Sequencing

Single-cell dissection of remodeled inflammatory ecosystem in primary and metastatic gallbladder carcinoma

Single-cell Characterization of Infiltrating T Cells Identifies Novel Targets for Gallbladder Cancer Immunotherapy

Single-cell transcriptome analysis reveals tumor immune microenvironment heterogenicity and granulocytes enrichment in colorectal cancer liver metastases

Single-cell RNA-sequencing atlas reveals an MDK-dependent immunosuppressive environment in ErbB pathway-mutated gallbladder cancer

Single-cell transcriptome analysis of tumor immune microenvironment characteristics in colorectal cancer liver metastasis

Integrative molecular characterisation of gallbladder cancer reveals micro-environment-associated subtypes

Revealing the transcriptional heterogeneity of organ‐specific metastasis in human gastric cancer using single‐cell RNA Sequencing

Single-cell Analysis Reveals Heterogeneity in the Molecular Profile of the Tumor Microenvironment of Biliary Tract Cancers

Single‐cell RNA‐seq dissecting heterogeneity of tumor cells and comprehensive dynamics in tumor microenvironment during lymph nodes metastasis in gastric cancer

Single-cell profiling reveals altered immune landscape and impaired NK cell function in gastric cancer liver metastasis

Comprehensive analysis of metastatic gastric cancer tumour cells using single-cell RNA-seq

RNA sequencing revealed the multi-stage transcriptome transformations during the development of gallbladder cancer associated with chronic inflammation

Spatiotemporal Immune Landscape of Colorectal Cancer Liver Metastasis at Single-Cell Level

Chromatin accessibility dynamics in colorectal cancer liver metastasis: Uncovering the liver tropism at single cell resolution

Dissecting the heterogeneities of the tumor microenvironment between metastatic and nonmetastatic primary colorectal cancer patients by single-cell RNA sequencing

Single-cell landscape reveals active cell subtypes and their interaction in the tumor microenvironment of gastric cancer

Single-cell and spatial transcriptome analysis reveals the cellular heterogeneity of liver metastatic colorectal cancer

Single‐cell RNA sequencing reveals cellular and molecular reprograming landscape of gliomas and lung cancer brain metastases

Single-cell RNA sequencing reveals cell subpopulations in the tumor microenvironment contributing to hepatocellular carcinoma